F. Ann Millner Sells 12,500 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 12,500 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $101.55, for a total value of $1,269,375.00. Following the transaction, the director now owns 32,391 shares in the company, valued at $3,289,306.05. This trade represents a 27.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Merit Medical Systems Stock Performance

MMSI opened at $104.71 on Wednesday. Merit Medical Systems, Inc. has a 1-year low of $65.46 and a 1-year high of $105.46. The company has a market capitalization of $6.10 billion, a price-to-earnings ratio of 51.33, a price-to-earnings-growth ratio of 2.53 and a beta of 0.89. The business has a 50 day moving average price of $97.93 and a two-hundred day moving average price of $90.28. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, topping the consensus estimate of $0.80 by $0.06. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The firm had revenue of $339.85 million for the quarter, compared to analysts’ expectations of $334.60 million. During the same period in the previous year, the business earned $0.75 earnings per share. Merit Medical Systems’s revenue for the quarter was up 7.8% compared to the same quarter last year. Research analysts predict that Merit Medical Systems, Inc. will post 3.36 EPS for the current fiscal year.

Analysts Set New Price Targets

MMSI has been the topic of several research reports. StockNews.com lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Needham & Company LLC restated a “buy” rating and set a $109.00 price objective on shares of Merit Medical Systems in a research report on Thursday, October 31st. Wells Fargo & Company increased their target price on Merit Medical Systems from $85.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Monday, September 16th. Barrington Research reissued an “outperform” rating and set a $114.00 price target on shares of Merit Medical Systems in a report on Thursday, October 31st. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $110.00 price objective (up previously from $100.00) on shares of Merit Medical Systems in a report on Monday, September 9th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.36.

Institutional Trading of Merit Medical Systems

Large investors have recently added to or reduced their stakes in the business. TD Private Client Wealth LLC increased its holdings in shares of Merit Medical Systems by 13.9% in the third quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock valued at $171,000 after buying an additional 211 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Merit Medical Systems by 1.3% during the third quarter. Geode Capital Management LLC now owns 1,357,265 shares of the medical instruments supplier’s stock worth $134,165,000 after purchasing an additional 17,490 shares during the period. Barclays PLC lifted its holdings in shares of Merit Medical Systems by 305.4% during the third quarter. Barclays PLC now owns 112,727 shares of the medical instruments supplier’s stock valued at $11,142,000 after purchasing an additional 84,923 shares during the last quarter. MML Investors Services LLC boosted its position in shares of Merit Medical Systems by 8.5% in the 3rd quarter. MML Investors Services LLC now owns 17,690 shares of the medical instruments supplier’s stock valued at $1,748,000 after purchasing an additional 1,390 shares during the period. Finally, XTX Topco Ltd purchased a new position in Merit Medical Systems in the 3rd quarter worth about $465,000. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.